HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC) incidence compared with aspirin, according to a study presented ...

Zanidatamab added to chemotherapy with or without trastuzumab prolonged progression-free survival in gastroesophageal cancer.

Plasma perfluorooctanoic acid concentration was linked to risk for metabolic dysfunction-associated steatotic liver disease among adolescents.

Patients with IBD and primary sclerosing cholangitis have markedly higher risks for colorectal and hepatobiliary cancers than those with isolated IBD or PSC.

A review of nursing quality assessment tools identified characteristics of commonly used instruments to measure nurse perception of care.

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Inpatient costs associated with alcohol-associated liver disease (ALD) increased from 2016 to 2019, according to a study in ...

AUD treatment engagement among patients with ALD remains low due to patient-provider discordance in need recognition, transplant-related stigma, and more.

Exercising 6 times per week for 30 minutes or more was associated with lower levels of stress, especially among women.

Researchers conducted a secondary analysis of the STEP TEENS trial to assess the effect of semaglutide 2.4 mg on insulin sensitivity in adolescent obesity.

More than half of Americans reported wanting to lose weight this year, although fewer were making a serious effort to do so.

Delayed remission with advanced therapies in IBD is not associated with worse 1-year clinical or endoscopic outcomes.